Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study (Q34279689)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study |
scientific article |
Statements
1 reference
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study (English)
1 reference
Kaj Blennow
1 reference
Bengt Winblad
1 reference
Lennart Minthon
1 reference
Matthias Staufenbiel
1 reference
Niels Andreasen
1 reference
Annette Floesser
1 reference
Georges Imbert
1 reference
Thomas Dumortier
1 reference
R Paul Maguire
1 reference
Joens Lundmark
1 reference
Jean-Marc Orgogozo
1 reference
Ana Graf
1 reference
1 reference
Identifiers
1 reference